Filing Flows

Filing Flows › Medtronic (MDT) › Guidance history

Medtronic (MDT) guidance history: what it guided and what it reported

Medtronic gave guidance in 12 earnings releases on file since Nov 21, 2023. Its releases raised guidance 8 times and lowered it 0 times.

GAAP EPS

Every guided period is still to be reported.

PeriodGuided (and how it moved)ReportedResultvs midpoint
FY27$0.96 (Jun 3, 2026) → raised $1.14 (Sep 1, 2026)—to be reported—

Adjusted EPS

The guide is on an adjusted basis that the GAAP statements do not show, so there is no reported figure to hold it to.

PeriodGuided (and how it moved)ReportedResultvs midpoint
FY27$1.55 (Jun 3, 2026) → raised $5.94–$6.00 (Sep 1, 2026)—to be reported—
FY26$5.50–$5.60 (May 21, 2025) → raised $5.60–$5.66 (Aug 19, 2025) → reaffirmed $5.62–$5.66 (Nov 18, 2025) → reaffirmed $5.62–$5.66 (Feb 17, 2026)———
FY25$5.40–$5.50 (May 23, 2024) → reaffirmed $5.42–$5.50 (Aug 20, 2024) → reaffirmed $5.44–$5.50 (Nov 19, 2024) → reaffirmed $5.44–$5.50 (Feb 18, 2025)———
FY24$5.13–$5.19 (Nov 21, 2023) → raised $5.19–$5.21 (Feb 20, 2024)———

The latest quarter

Medtronic, Q1 FY27: revenue $9.8B (+14% year over year), operating margin 18.1%, net earnings $1.5B, operating cash flow $1.8B. The chart follows the revenue to costs, profit and cash.

Questions

Does Medtronic beat its guidance?

Medtronic gave guidance in 12 earnings releases on file since Nov 21, 2023. Its releases raised guidance 8 times and lowered it 0 times.

How often does Medtronic raise guidance?

Its earnings releases raised guidance 8 times and lowered it 0 times since Nov 21, 2023.

Latest guidance and outlook →

Each guided period is held to the last guidance given before its figures were reported; a single figure counts as in line within 1% (0.25 pts for a rate). Reported figures are GAAP, from the company's filings; adjusted guidance shows its moves only.